|
|
Article: Two Landmark Studies Report Encouraging New Data on Children's Growth and Asthma Control With Long-term Use of Inhaled Corticosteroid - New England Journal of Medicine.
- Article from:
- PR Newswire
- Article date:
- October 12, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WAYNE, Pa., Oct. 11 /PRNewswire/ --
Millions of children suffer from asthma, a serious, inflammatory lung disease that can be life-threatening when poorly controlled. Inhaled corticosteroids are recommended by the National Institutes of Health (NIH) as the most effective anti-inflammatory treatments to help control persistent asthma -- although there has been limited research on their long-term use. Now two landmark studies reported today in the New England Journal of Medicine show encouraging new data on asthma management and children's growth with long-term use of Pulmicort(R) (budesonide), an inhaled corticosteroid, made by AstraZeneca.
Given the ...